Patents Assigned to LIMITED LIABILITY COMPANY BIOCHEMICAL AGENT
  • Patent number: 11299724
    Abstract: The invention relates to molecular biology, biotechnology, medicine, veterinary science. A group of inventions is proposed: a fusion protein comprising a ligand to MATN1 protein, and a growth factor of EGF, TGF, FGF, IGF, connected via a flexible link; such fusion protein further comprising the Fc-fragment of an antibody or a polypeptide binding with FcRn and/or transferrin or a fragment thereof, connected via a flexible link; encoding polynucleotide, a genetic construct for the synthesis of the fusion protein in producer cells, or cells of a target organism, the fusion protein producer, a producer of the genetic construct, a preparation for the regeneration of cartilage containing at least 1 fusion protein or genetic construct, for parenteral or, in the case of the preparation based on at least 1 fusion protein containing the transport domain, —oral administration, in the latter case the preparation is enclosed in an enteric coating.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: April 12, 2022
    Assignee: LIMITED LIABILITY COMPANY BIOCHEMICAL AGENT
    Inventors: Ilya Vladimirovich Dukhovlinov, Ekaterina Alekseevna Fedorova